Actor Rob Lowe Partners with Eli Lilly to Boost Cancer Clinical Trial Enrollment

LOS ANGELES — Actor Rob Lowe is stepping into a new role off-screen, partnering with pharmaceutical giant Eli Lilly to encourage more cancer patients to enroll in clinical trials—addressing a critical challenge that currently bottlenecks cancer research across the United States.

For Lowe, the advocacy work is deeply personal. Three generations of women in his family—his great-grandmother, grandmother, and mother—all battled breast cancer and eventually passed away from the disease. Lowe recalls navigating the peak of his Hollywood film career while simultaneously coming home to care for his family members, an experience he says serves as a constant reminder of what truly matters.

According to data from the National Cancer Institute, roughly 2 million people will be diagnosed with cancer in the U.S. this year alone. While medical research and cancer treatments have advanced dramatically in recent decades, oncology experts warn that many promising, potentially life-saving therapies are failing to reach the public simply because researchers cannot find enough participants.

Dr. Edward Kim, an oncologist and the System Director of Clinical Trials at City of Hope in California, noted that less than 5% of the cancer population currently enrolls in clinical trials. This low participation rate is highly problematic for the medical community. Data from the American Cancer Society indicates that up to 20% of clinical trials fail completely because they cannot meet their required enrollment numbers.

Dr. Kim pointed to strict eligibility criteria, long travel distances to trial sites, and a general lack of awareness among both doctors and patients as the primary barriers preventing trials from getting off the ground. He also addressed a common historical misconception that keeps patients from signing up: the fear of receiving a placebo instead of active medicine. Kim explained that standard protocols have changed significantly since the late 1990s, and it is now rare to see trials with placebo arms, ensuring that clinical trial participants receive at least the standard of care they would normally get.

For patients like 25-year-old Serene Hesri, entering a trial proved to be a life-saving decision. Diagnosed with Hodgkin's lymphoma during the pandemic, Hesri relapsed and turned to an experimental clinical trial at City of Hope for another chance at survival. When asked if she was apprehensive about testing an entirely experimental treatment, Hesri recalled asking her oncologist what he would truly recommend. He looked her in the eye and told her that if she were his own daughter, he would advise her to do the trial. Today, Hesri firmly believes she is alive because of that study.

Lowe credits a clinical trial with giving his own grandmother, whom he affectionately called Mim, nearly 20 additional years of life that she otherwise would not have had. Reflecting on his new advocacy partnership, Lowe smiled and noted that if his grandmother were alive to see him pushing for clinical trial awareness, she would probably tell him to cut his hair, but would ultimately be thrilled that her story is being used as a real-world example of the hope that clinical trials can offer.

Explore NBCPalmSprings.com, where we are connecting the valley.